L. Peng et al. / Journal of Organometallic Chemistry 696 (2011) 118e122
121
6.6 Hz,1H), 5.60 (t, J ¼ 6.6 Hz,1H), 7.26e7.50 (m, 9H), 8.22 (s,1H); 13
C
(CDCl3, 300 MHz)
d
¼ 3.80 (s, 3H), 4.41 (d, J ¼ 11.1 Hz, 1H), 4.50
NMR (CDCl3, 75 MHz)
d
¼ 56.40, 71.78, 79.06, 91.00, 93.22, 121.67,
(dd, J ¼ 11.1, 6.6 Hz, 1H), 4.59 (d, J ¼ 11.1 Hz, 1H), 4.80 (dd, J ¼ 11.1,
128.51, 129.46, 129.78, 130.34, 131.02, 137.87, 139.18, 162.07, 207.61.
EI-MS (m/z, relative intensity): 491 (Mþ, 1), 414 (3), 382 (44), 330
(30), 318 (18), 249 (29), 219 (95), 140 (100), 109 (85), 44 (61). HRMS
calcd for C19H15ONS35Cl739Br [Mþ] 488.9123; Found: 488.9119.
2-(4-Methoxyphenyl)-2-(phenylthio)penta-3,4-dienyl 2,2,2-tri-
chloroacetimidate (4c). yield 85%; IR (film) 3341, 2955, 2835, 1953,
6.6 Hz, 1H), 5.66 (t, J ¼ 6.6 Hz, 1H), 6.80e6.84 (m, 1H), 7.20e7.47
(m, 8H), 8.19 (s, 1H); 13C NMR (CDCl3, 75 MHz)
d
¼ 55.23, 56.85,
72.03, 78.80, 91.13, 93.50, 113.18, 113.89, 120.25, 128.42, 128.95,
129.33, 130.79, 137.97, 141.60, 159.22, 162.25, 207.60. EI-MS (m/
z, relative intensity): 441 (Mþ, 0.4), 332 (16), 280 (17), 171 (100),
141 (25), 44 (20). HRMS calcd for C20H18O2NS35Cl3 [Mþ] 441.0124;
Found: 441.0126.
1663, 1510, 1300, 1252, 1182, 1086, 1031, 828, 795, 750, 693 cmꢁ1
1H NMR (CDCl3, 300 MHz)
;
d
¼ 3.79 (s, 3H), 4.40 (d, J ¼ 11.1 Hz, 1H),
2-(3-Chlorophenyl)-2-(phenylthio)penta-3,4-dienyl 2,2,2-tri-
chloroacetimidate (4i). Yield 92%; IR (film) 3339, 1952, 1664,
4.50 (dd, J ¼ 10.8, 6.6 Hz, 1H), 4.58 (d, J ¼ 11.1 Hz, 1H), 4.79 (dd, J ¼
10.8, 6.6 Hz, 1H), 5.65 (t, J ¼ 6.6 Hz, 1H), 6.83e6.88 (m, 2H),
1302, 1086, 999, 854, 829, 795, 750, 692 cmꢁ1 1H NMR (CDCl3,
;
7.25e7.56 (m, 7H), 8.19 (s, 1H); 13C NMR (CDCl3, 75 MHz)
d
¼ 55.21,
300 MHz)
4.84 (dd, J ¼ 11.1, 6.9 Hz, 1H), 5.61 (t, J ¼ 6.9 Hz, 1H), 7.25e7.52
(m, 8H), 7.63 (s, 1H), 8.22 (s, 1H); 13C NMR (CDCl3, 75 MHz)
d
¼ 4.40 (d, J ¼ 11.1 Hz, 1H), 4.52e4.58 (m, 2H),
56.47, 72.10, 78.73, 91.18, 93.75, 113.31, 128.42, 129.15, 129.26,
131.01, 132.02, 137.92, 158.89, 162.31, 207.60. EI-MS (m/z, relative
intensity): 441 (Mþ, 8), 332 (15), 318 (14), 280 (66), 171 (50), 133
(100), 77 (22), 44 (92). HRMS calcd for C20H18O325Cl3SN [Mþ]
441.0124; Found: 441.0114.
d
¼
56.44, 71.78, 79.14, 91.01, 93.17, 126.13, 127.79, 128.56, 129.22,
129.56, 130.26, 133.92, 137.99, 142.15, 162.14, 207.64. EI-MS (m/z,
relative intensity): 445 (Mþ, 5), 368 (15), 336 (12), 284 (11), 175
(100), 139 (22), 109 (28). HRMS calcd for C19H15ONS35Cl4 [Mþ]
444.9629; Found: 444.9636.
2-(3,4-Dichlorophenyl)-2-(phenylthio)penta-3,4-dienyl 2,2,2-
trichloroacetimidate (4d). Yield 87%; IR (film) 3340, 1953, 1664,
1469, 1380, 1302, 1086, 1029, 855, 824, 795, 751, 693 cmꢁ1 1H
;
NMR (CDCl3, 300 MHz)
d
¼ 4.40 (d, J ¼ 11.1 Hz, 1H), 4.52 (d, J ¼ 11.1
Hz, 1H), 4.58 (dd, J ¼ 11.1, 6.6 Hz, 1H), 4.85 (dd, J ¼ 11.1, 6.6 Hz, 1H),
4.3. General procedure for [RuCl2(p-cymene)]2-catalyzed reaction
of 2-aryl-2-(phenylthio)penta-3,4-dienyl 2,2,2-trichloroacetimidate
4a-i
5.57 (t, J ¼ 6.6 Hz, 1H), 7.26e7.48 (m, 7H), 7.72 (d, J ¼ 2.1 Hz, 1H),
8.25 (s, 1H); 13C NMR (CDCl3, 75 MHz)
d
¼ 56.08, 71.68, 79.35,
90.98, 93.04, 127.47, 128.67, 129.72, 129.83, 130.04, 130.48, 131.71,
132.10, 137.93, 140.49, 162.09, 207.69. EI-MS (m/z, relative inten-
sity): 479 (Mþ, 0.4), 370 (13), 318 (8), 209 (100), 175 (21), 139 (36),
109 (52). HRMS calcd for C19H14ONS35Cl5 [Mþ] 478.9239; Found:
478.9255.
Under
a nitrogen atmosphere, [RuCl2(p-cymene)]2 (0.025
mmol) and 2-aryl-2-(phenylthio)penta-3,4-dienyl 2,2,2-tri-
chloroacetimidate 4a-i were mixed in anhydrous DCE (5 mL) in a 25
mL round-bottomed flask. The reaction was continued at room
temperature [for some examples the reaction temperature was 60
ꢀC (oil-bath)] until completed as judged by TLC. Removal of the
solvent in vacuo gave a crude residue, which was purified by silica
gel column. Elution with petroleum ether/ethyl acetate (200:1)
afforded pure product of 5a i.
2-(4-Chloroheny)-2-(phenylthio)penta-3,4-dienyl
chloroacetimidate (4e). Yield 82%; IR (film) 3341, 1953, 1663, 1491,
1303, 1093, 1013, 827, 795, 750, 693 cmꢁ1 1H NMR (CDCl3, 300
MHz)
¼ 4.42 (d, J ¼ 11.1 Hz, 1H), 4.52e4.59 (m, 2H), 4.82 (dd, J ¼
11.1, 6.6 Hz,1H), 5.61 (t, J ¼ 6.6 Hz,1H), 7.26e7.44 (m, 7H), 7.52e7.57
(m, 2H), 8.22 (s, 1H); 13C NMR(CDCl3, 75 MHz)
79.08, 91.05, 93.33, 128.11, 128.56, 129.49, 130.44, 133.48, 137.92,
138.68, 162.19, 207.68. EI-MS (m/z, relative intensity): 445
(Mþ, 0.6), 336 (43), 272 (18), 193 (27), 175 (100), 139 (68), 109 (93).
HRMS calcd for C19H15ONS35Cl4 [Mþ] 444.9629; Found: 444.9632.
2,2,2-tri-
;
d
d
¼ 56.39, 71.91,
(Z)-2,2,2-Trichloro-N-(4-phenyl-1-(phenylthio)penta-2,4-dien-
2-yl)acetamide (5a). IR (film) 3357, 3058, 1724, 1644, 1494, 902,
811, 766, 744, 706, 692 cmꢁ1
;
1H NMR (CDCl3, 300 MHz)
d
¼ 4.18
(s, 2H), 5.21 (s, 1H), 5.52 (s, 1H), 5.64 (s, 1H), 6.96e6.99 (m, 2H),
7.21e7.50 (m, 8H), 7.94 (s, 1H); 13C NMR (CDCl3, 75 MHz)
d
¼
2-(4-Nitrophenyl)-2-(phenylthio)penta-3,4-dienyl
2,2,2-tri-
38.53, 92.46, 117.84, 120.21, 126.58, 127.49, 128.38, 128.76, 129.03,
132.40, 132.63, 134.01, 138.68, 142.23, 158.38. EI-MS (m/z, relative
intensity): 411 (Mþ, 22), 302 (79), 230 (26), 156 (44), 141 (100), 115
(56), 77 (44). HRMS calcd for C19H16O35Cl3SN [Mþ] 411.0018;
Found: 411.0020.
chloroacetimidate (4f). Yield 89%; IR (film) 3338, 1953, 1665, 1520,
1348, 1302,1085, 855, 833, 795, 750, 693 cmꢁ1; 1H NMR (CDCl3, 300
MHz)
d
¼ 4.51 (d, J ¼ 11.1 Hz, 1H), 4.62e4.68 (m, 2H), 4.89 (dd, J ¼
11.1, 6.6 Hz, 1H), 5.63 (t, J ¼ 6.6 Hz, 1H), 7.27e7.43 (m, 5H), 7.76 (dd, J
¼ 6.9, 2.1 Hz, 2H), 8.18 (dd, J ¼ 6.9, 2.1 Hz, 2H), 8.28 (s, 1H); 13C NMR
(Z)-2,2,2-Trichloro-N-(4-(4-bromophenyl)-1-(phenylthio)
penta-2,4-dien-2-yl)acetamide (5b). IR (film) 3365, 3073, 1725,
(CDCl3, 75 MHz)
d
¼ 56.48, 71.69,79.54, 90.89, 92.89, 123.06,128.75,
129.20, 129.72, 129.85, 137.86, 147.09, 147.61, 162.01, 207.79. EI-MS
(m/z, relative intensity): 456 (Mþ, 2), 379 (6), 347 (32), 295 (34), 218
(27), 186 (100), 139 (61), 109 (76), 44 (77). HRMS calcd for
C19H15O3N2S35Cl3 [Mþ] 455.9869; Found: 455.9859.
1645, 1487, 1071, 1009, 902, 834, 817, 744, 692 cmꢁ1 1H NMR
;
(CDCl3, 300 MHz)
d
¼ 4.14 (s, 2H), 5.23 (s, 1H), 5.54 (s, 1H), 5.59
(s, 1H), 6.80 (d, J ¼ 8.7 Hz, 2H), 7.33e7.49 (m, 7H), 7.93 (s, 1H); 13C
NMR (CDCl3, 75 MHz)
d
¼ 38.62, 92.51, 117.88, 119.96, 122.44,
2-(3-Methylphenyl)-2-(phenylthio)penta-3,4-dienyl 2,2,2-tri-
chloroacetimidate (4g). Yield 97%; IR (film) 3340, 1953, 1663, 1303,
1087, 998, 852, 831, 796, 752, 702, 693 cmꢁ1; 1H NMR (CDCl3, 300
127.57, 128.18, 129.09, 131.71, 132.60, 132.75, 133.91, 137.62,
141.29, 158.38. EI-MS (m/z, relative intensity): 491 (Mþ,32), 382
(100), 347 (11), 330 (13), 301 (14), 237 (31), 109 (46), 77 (26).
HRMS calcd for C19H15ONS35Cl739Br [Mþ] 488.9123; Found:
488.9125.
MHz)
d
¼ 2.34 (s, 3H), 4.40 (d, J ¼ 11.1 Hz, 1H), 4.48 (dd, J ¼ 11.1, 6.6
Hz,1H), 4.57 (d, J ¼ 11.1 Hz,1H), 4.79 (dd, J ¼ 11.1, 6.6 Hz,1H), 5.66 (t,
J ¼ 6.6 Hz,1H), 7.07e7.09 (m,1H), 7.19e7.47 (m, 8H), 8.18 (s, 1H); 13C
(Z)-2,2,2-Trichloro-N-(4-(4-methoxyphenyl)-1-(phenylthio)
penta-2,4-dien-2-yl)acetamide (5c). IR (film) 3356, 2958, 2836,
1723, 1644, 1606, 1509, 1250, 1178, 1031, 837, 814, 744, 692 cmꢁ1; 1H
NMR (CDCl3, 75 MHz)
d
¼ 21.52, 56.78, 71.96, 78.72, 91.17, 93.62,
124.90,127.90,128.35, 128.39, 128.69, 129.29, 130.90, 137.52,138.04,
139.86, 162.27, 207.57. EI-MS (m/z, relative intensity): 425 (Mþ, 0.6),
316 (14), 264 (8), 155 (100), 128 (10), 77 (6). HRMS calcd for
C20H18ONS35Cl3 [Mþ] 425.0175; Found: 425.0161.
NMR (CDCl3, 300 MHz)
d
¼ 3.79 (s, 3H), 4.18 (s, 2H), 5.11 (s,1H), 5.46
(s, 1H), 5.61 (s, 1H), 6.77 (dd, J ¼ 6.9, 2.1 Hz, 1H), 6.91 (dd, J ¼ 6.9, 2.1
Hz, 1H), 7.32e7.38 (m, 3H), 7.46e7.50 (m, 2H), 8.03 (s, 1H); 13C NMR
2-(3-Methoxyphenyl)-2-(phenylthio)penta-3,4-dienyl
2,2,2-
(CDCl3, 75 MHz)
d
¼ 38.44, 55.32, 92.58, 114.10, 116.01, 120.29,
trichloroacetimidate (4h). Yield 92%; IR (film) 3337, 1953, 1663,
127.42, 127.84, 129.01, 131.08, 132.45, 132.57, 134.17, 141.61, 158.37,
1291, 1260, 1086, 1039, 998, 853, 831, 796, 753, 694 cmꢁ1; 1H NMR
159.88. EI-MS (m/z, relative intensity): 441 (Mþ, 5), 332 (17), 296